Karyopharm Initiates Registration-Directed Clinical Study of Selinexor (KPT-330) in Patients With Richter's Transformation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/11/2026

1. SKHY
2. USO
3. SPY
4. META
5. DAL
6. PEP
7. SKHYV
8. ALP
9. GTM
10. NVDA

Go back to Karyopharm Initiates Registration-Directed Clinical Study of Selinexor (KPT-330) in Patients With Richter's Transformation
KARYOPHARM THERAP (NASDAQ: KPTI) Delayed: 10.34 +0.14 (1.37%)
Previous Close $10.20    52 Week High $19.41 
Open $10.30    52 Week Low $4.83 
Day High $10.59    P/E N/A 
Day Low $9.88    EPS $-2.74 
Volume 320,249